Takeda Pharmaceutical (TAK) Dividends Paid - Common (2018 - 2026)

Takeda Pharmaceutical has reported Dividends Paid - Common for 9 years, with the latest figure at -$941.9 million in Q2 2026.

• On a quarterly basis, Dividends Paid - Common rose 6.2% year-over-year to -$941.9 million in Q2 2026; TTM through Jun 2026 was -$2.1 billion, a 0.81% increase from a year earlier, with the FY2026 full-year figure at -$2.0 billion, changed 0.15% from the prior year.
• Dividends Paid - Common was -$941.9 million for Q2 2026 at Takeda Pharmaceutical, down from -$59.6 million in the prior quarter.
• The five-year high for Dividends Paid - Common was -$59.6 million in Q3 2025, with the low at -$1.0 billion in Q2 2025.
• Average Dividends Paid - Common over 5 years is -$509.3 million, with a median of -$489.4 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Dividends Paid - Common increased 22.14% in 2023, then retreated 13.18% in 2025.
• Over 5 years, Dividends Paid - Common stood at -$913.0 million in 2022, then fell by 2.44% to -$935.3 million in 2023, then fell by 2.29% to -$956.7 million in 2024, then jumped by 93.77% to -$59.6 million in 2025, then plunged by 1479.45% to -$941.9 million in 2026.
• The last three Dividends Paid - Common figures came in at -$941.9 million (Q2 2026), -$59.6 million (Q3 2025), and -$1.0 billion (Q2 2025), per Business Quant data.